Development and evaluation of a solid oral dosage form for an artesunate and mefloquine drug combination / Abel Hermanus van der Watt
Malaria affects about forty percent of the world’s population. Annually more than 1.5 million fatalities due to malaria occur and parasite resistance to existing antimalarial drugs such as mefloquine has already reached disturbingly high levels in South-East Asia and on the African continent. Conseq...
Main Author: | Van der Watt, Abel Hermanus |
---|---|
Language: | en |
Published: |
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/10394/10809 |
Similar Items
-
Development and evaluation of a solid oral dosage form for an artesunate and mefloquine drug combination / Abel Hermanus van der Watt
by: Van der Watt, Abel Hermanus
Published: (2014) -
Development and evaluation of an oral fixed–dose triple combination dosage form for artesunate, dapsone and proguanil / van der Merwe, A.J.
by: Van der Merwe, Adriana Johanna
Published: (2012) -
Development and evaluation of an oral fixed–dose triple combination dosage form for artesunate, dapsone and proguanil / van der Merwe, A.J.
by: Van der Merwe, Adriana Johanna
Published: (2012) -
Successful Treatment of Imported Cerebral Malaria with Artesunate-Mefloquine Combination Therapy
by: Hsin-Yun Sun
Published: (2006-01-01) -
Population pharmacokinetics of mefloquine given as a 3-day artesunate–mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai–Myanmar border
by: Richard M. Hoglund, et al.
Published: (2018-09-01)